Anne Mary Stephenson

Title: The Innovations of Anne Mary Stephenson

Introduction

Anne Mary Stephenson is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of neuroscience through her innovative work. With a total of two patents to her name, her research focuses on compounds that target orexin receptors, which are crucial in the treatment of neurological and psychiatric disorders.

Latest Patents

Stephenson's latest patents include novel compounds of formula (I) and their salts, specifically designed as Orexin 1 receptor antagonists. These compounds are aimed at treating, preventing, ameliorating, controlling, or reducing the risk of neurological or psychiatric disorders associated with orexin receptors. Her work in this area is groundbreaking and has the potential to impact many lives positively.

Career Highlights

Currently, Anne Mary Stephenson is associated with Nxera Pharma UK Limited, where she continues her research and development efforts. Her expertise in the field has positioned her as a key player in the pharmaceutical industry, particularly in the realm of neurological treatments.

Collaborations

Throughout her career, Stephenson has collaborated with esteemed colleagues such as Giles Albert Brown and Miles Stuart Congreve. These partnerships have further enhanced her research capabilities and contributed to the advancement of her projects.

Conclusion

Anne Mary Stephenson's work exemplifies the spirit of innovation in the field of neuroscience. Her contributions through her patents and collaborations are paving the way for new treatments that could significantly improve the quality of life for individuals with neurological disorders.